Boundless Bio, Inc. (BOLD)
Boundless Bio Market Cap : 53.61M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 53.61M |
| November 19, 2026 | 55.00M |
| November 18, 2026 | 55.46M |
| November 17, 2026 | 55.69M |
| November 16, 2026 | 55.69M |
| November 13, 2026 | 57.77M |
| November 12, 2026 | 56.85M |
| November 11, 2026 | 56.85M |
| November 10, 2026 | 56.62M |
| November 09, 2026 | 56.85M |
| November 06, 2026 | 56.85M |
| November 05, 2026 | 55.69M |
| November 04, 2026 | 53.94M |
| November 03, 2026 | 53.49M |
| November 02, 2026 | 54.84M |
| October 30, 2026 | 55.51M |
| October 29, 2026 | 55.74M |
| October 28, 2026 | 56.19M |
| October 27, 2026 | 54.16M |
| October 26, 2026 | 54.16M |
| October 23, 2026 | 53.04M |
| October 22, 2026 | 54.84M |
| October 21, 2026 | 54.84M |
| October 20, 2026 | 54.61M |
| October 19, 2026 | 51.92M |
| Date | Value |
|---|---|
| October 16, 2026 | 52.59M |
| October 15, 2026 | 52.82M |
| October 14, 2026 | 53.72M |
| October 13, 2026 | 54.61M |
| October 12, 2026 | 57.31M |
| October 09, 2026 | 56.86M |
| October 08, 2026 | 57.99M |
| October 07, 2026 | 59.33M |
| October 06, 2026 | 57.76M |
| October 05, 2026 | 58.44M |
| October 02, 2026 | 58.88M |
| October 01, 2026 | 58.21M |
| September 30, 2026 | 56.41M |
| September 29, 2026 | 57.54M |
| September 28, 2026 | 58.66M |
| September 25, 2026 | 59.78M |
| September 24, 2026 | 58.44M |
| September 23, 2026 | 60.68M |
| September 22, 2026 | 64.73M |
| September 21, 2026 | 63.60M |
| September 18, 2026 | 63.15M |
| September 17, 2026 | 62.93M |
| September 16, 2026 | 63.38M |
| September 15, 2026 | 63.15M |
| September 14, 2026 | 63.83M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.956B |
| Alnylam Pharmaceuticals, Inc. | 19.25B |
| Anika Therapeutics, Inc. | 177.20M |
| Savara, Inc. | 875.58M |
| Arrowhead Pharmaceuticals, Inc. | 5.845B |
Market Cap Related Metrics
| Price to Book Value | 0.8686 |
| Price | 2.32 |
| Earnings Yield | -106.5% |